A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)

NCT04883658 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension and Dyslipidemia

Interventions

DRUG: CKD-348(2)
DRUG: CKD-828, D097, D337

Sponsor

Chong Kun Dang Pharmaceutical